Published in J Pediatr on September 01, 2001
Pediatric multiple sclerosis. Nat Rev Neurol (2009) 1.50
Therapeutic strategies in childhood multiple sclerosis. Ther Adv Neurol Disord (2010) 1.01
Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol (2011) 0.93
Pediatric multiple sclerosis. Ann Indian Acad Neurol (2009) 0.84
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience. Neurol Sci (2009) 0.84
Pediatric multiple sclerosis. NeuroRx (2006) 0.84
Natalizumab in pediatric multiple sclerosis patients. Ther Adv Neurol Disord (2010) 0.82
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis. Neurotherapeutics (2016) 0.81
Paediatric UK demyelinating disease longitudinal study (PUDDLS). BMC Pediatr (2011) 0.81
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Mult Scler (2013) 0.80
Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update. Curr Neuropharmacol (2010) 0.78
Treatment of Pediatric Multiple Sclerosis. Curr Treat Options Neurol (2005) 0.78
Management of multiple sclerosis in adolescents - current treatment options and related adherence issues. Adolesc Health Med Ther (2010) 0.77
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies. Adolesc Health Med Ther (2010) 0.77
Disease-modifying therapy of pediatric multiple sclerosis. Neurotherapeutics (2013) 0.77
IVIG therapy in neurological disorders of childhood. J Neurol (2006) 0.76
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell (1990) 8.30
Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency. Cell (1985) 7.95
WT-1 is required for early kidney development. Cell (1993) 7.05
Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med (1998) 5.22
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med (1998) 4.65
A cellular protein that binds to the 5'-noncoding region of poliovirus RNA: implications for internal translation initiation. Genes Dev (1989) 4.35
Relapses and progression of disability in multiple sclerosis. N Engl J Med (2000) 4.17
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
LEAFY COTYLEDON2 encodes a B3 domain transcription factor that induces embryo development. Proc Natl Acad Sci U S A (2001) 3.66
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology (1999) 3.49
Unusual MR findings of the brain stem in arterial hypertension. AJNR Am J Neuroradiol (2000) 3.47
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
The candidate Wilms' tumour gene is involved in genitourinary development. Nature (1990) 3.13
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell (1990) 3.02
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology (2005) 2.95
Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci U S A (1991) 2.83
Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies. J Virol (1991) 2.75
Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms. Int J Pharm (2001) 2.53
Translation in mammalian cells of a gene linked to the poliovirus 5' noncoding region. Science (1988) 2.53
Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology (2005) 2.53
The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology (2001) 2.15
Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology (2003) 2.03
Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development (1993) 2.02
Bilateral porencephalic defect in a newborn after injection of benzol during pregnancy. Brain Dev (1991) 1.98
Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5' untranslated region. Proc Natl Acad Sci U S A (1985) 1.94
Photochemical cross-linking of cap binding proteins to eucaryotic mRNAs: effect of mRNA 5' secondary structure. Mol Cell Biol (1985) 1.93
Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet (1988) 1.93
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry (2008) 1.84
Assessment of the total number of human transcription units. Genomics (2001) 1.82
Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet (1994) 1.76
Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology (2010) 1.75
An efficient strategy to isolate full-length cDNAs based on an mRNA cap retention procedure (CAPture). Mol Cell Biol (1995) 1.70
Absence of p53 gene mutations in primary neuroblastomas. Cancer Res (1993) 1.69
Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J Neurol Sci (1988) 1.67
Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (1995) 1.67
Multiple sclerosis and antecedent infections: a case-control study. Neurology (2000) 1.66
Translation initiation factor-dependent extracts from Saccharomyces cerevisiae. Biochim Biophys Acta (1990) 1.64
Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol (1987) 1.63
Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol (1991) 1.63
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet (2001) 1.62
Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med (2000) 1.57
Identification of a new polypeptide coded by reovirus gene S1. J Virol (1985) 1.57
Electroencephalographic aspects of hemimegalencephaly. Dev Med Child Neurol (1989) 1.51
Intravenous immunoglobulin treatment in multifocal motor neuropathy. Lancet (1992) 1.50
Neuromyelitis optica and pregnancy. Neurology (2012) 1.49
Microangiopathy of the inner ear, retina, and brain (Susac syndrome): report of a case. Arch Otolaryngol Head Neck Surg (2000) 1.47
Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain. Genomics (1998) 1.45
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler (2007) 1.45
doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH). Hum Mol Genet (1998) 1.44
A mammalian translation initiation factor can substitute for its yeast homologue in vivo. J Biol Chem (1989) 1.44
A lysine substitution in the ATP-binding site of eucaryotic initiation factor 4A abrogates nucleotide-binding activity. Mol Cell Biol (1989) 1.43
A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci (1998) 1.43
Paroxysmal kinesigenic choreoathetosis as a presenting symptom of multiple sclerosis. J Neurol (2000) 1.42
[An unusual cause of long-term fever: Behçet disease]. Presse Med (2000) 1.41
Gordona terrae central nervous system infection in an immunocompetent patient. J Clin Microbiol (1997) 1.41
The murine Sim-2 gene product inhibits transcription by active repression and functional interference. Mol Cell Biol (1997) 1.40
Clinical parameters to predict response to interferon in relapsing multiple sclerosis. Neuroepidemiology (2008) 1.40
Long-term follow-up of neurosarcoidosis. Neurology (2001) 1.36
Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol (1999) 1.34
Association of multiple sclerosis with ILT6 deficiency. Genes Immun (2005) 1.34
Intrathecal synthesis of different alpha-interferons in patients with various neurological diseases. Acta Neurol Scand (1985) 1.34
Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci (2002) 1.33
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. J Clin Invest (1996) 1.33
Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci (2006) 1.32
The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene (1996) 1.31
Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet (1996) 1.30
Putaminal necrosis after methanol intoxication. J Neurol Neurosurg Psychiatry (1992) 1.30
[Spontaneous hyperdense intracranial vessels seen on CT scan in polycythemia cases]. J Radiol (2003) 1.30
Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet (2001) 1.30
Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med (1985) 1.29
Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene (1998) 1.28
Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperone. Genomics (1997) 1.28
Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat Genet (1992) 1.28
Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol (1995) 1.27
A regression survival model for testing the proportional hazards hypothesis. Biometrics (1996) 1.27
Full-length cDNAs: more than just reaching the ends. Physiol Genomics (2001) 1.23
A parametric study of the destruction efficiency of Bacillus spores in low pressure oxygen-based plasmas. Lett Appl Microbiol (1998) 1.22
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology (2008) 1.21
The effect of poliovirus proteinase 2Apro expression on cellular metabolism. Inhibition of DNA replication, RNA polymerase II transcription, and translation. J Biol Chem (1991) 1.20
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20
Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler (2007) 1.19